PODD
Insulet Corp. · Healthcare · Medical - Devices
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -0.7% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | 0 | 52.88M | $8.06B | +7 | −8 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 2.97M | n/a | $776.57M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 2.36M | +3.5% | $615.00M | 0.5% | ▲ Add | 3 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (pasif) | 1.78M | +2.3% | $463.35M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasif) | 953.02K | +7.4% | $248.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 729.11K | -26.4% | $190.35M | 0.2% | ▼ Trim | 3 | SEC ↗ ×2 |
| 6 | PRIMECAP Management ✦ | 493.22K | -10.7% | $128.76M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 486.52K | +29.6% | $127.01M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Fisher Asset Management ✦ | 377.69K | +7.6% | $98.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 325.33K | -3.5% | $84.93M | 0.0% | ▼ Trim | 3 | SEC ↗ ×8 |
| 10 | T. Rowe Price ✦ | 202.73K | +0.4% | $52.93M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Capital World Investors ✦ | 168.00K | 0.0% | $43.86M | 0.0% | Held | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 158.99K | +45.7% | $41.51M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 158.13K | -8.4% | $41.28M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 155.50K | -39.6% | $40.60M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 100.16K | -18.8% | $26.15M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 16 | Arrowstreet Capital ✦ | 37.62K | Baru | $9.82M | 0.0% | New | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 16.98K | -56.6% | $4.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 7.73K | -30.6% | $2.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 6.83K | +57.2% | $1.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $9.82M | 0.0% |
Telah keluar
| D. E. Shaw & Co. | $269,525 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 779 pemegang, 69.27M saham, $13.82B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Officer, Director · President and CEO · 1.10K lbr @ 147.47 · $162,217
Penjualan di pasar terbuka (S)
Tidak ada penjualan insider di pasar terbuka dalam jendela cakupan kami.
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi